Xarelto Lawsuit Information
Patients who took Xarelto are filing lawsuits after the drug caused severe injuries and uncontrolled bleeding, a side effect for which no antidote is currently available. The dangerous effects of Bayer’s controversial oral blood thinner may, in fact, lead to life-threatening internal haemorrhages, strokes or gastrointestinal bleeds. If you or a loved one have been harmed by taking this anticoagulant medication, you might be eligible for compensation. Call right now to speak to some of the best Xarelto Lawyers in the country that will help guide you through your legal options for free. Don’t delay! Time is running out to collect your reward.
Call Now Toll-Free Number: 1-800-553-0710
Why should you file a Xarelto lawsuit?
Since Xarelto (rivaroxaban) received approval in 2011, Bayer AG and Janssen Pharmaceuticals (a Johnson & Johnson’s subsidiary) made millions by selling this Novel Oral Anticoagulant (NOAC) to US patients. This blood thinner is used to prevent blood clots and strokes in people who suffer from Atrial Fibrillation (Afib), Pulmonary Embolism (PE), and Deep Vein Thrombosis (DVT). However, this drug is also very dangerous, as it may cause uncontrollable bleedings that cannot be stopped since there is no antidote available to reverse its effects. Many people who were injured by its side effects filed a litigation against the manufacture pharmaceutical companies Bayer, Johnson & Johnson’s and Janssen Pharmaceuticals, holding them accountable for the harm they suffered. Both Bayer and J&J, in fact, never warned patients properly about the medication’s risk. Filing a dispute against the manufacturers of this blood thinner is the only way to get compensation for all the damages you have sustained, including emotional injuries, financial loss and even the death of a loved one. Plaintiffs’ principal accusations include negligence and failure to warn since the absence of a strong warning label about its complications prevented doctors from adequately understanding the real dangers associated with this drug. Patients who switched from older (and allegedly safer) anticoagulant drugs to this one, should now be scared even by the mildest trauma since just a simple bump or fall may cause a potentially fatal bleeding. The pharmaceutical companies only focused on the drug’s safety and benefits, and never thoroughly explained its risks, including the lack of a proper reversal agent.
Why should you choose us as your Xarelto lawyer?
Over the years, our lawyers have been consistently winning cases for their victims, granting them the rightful compensation for all their suffering. We have been featured in several publications and seen across more than a dozen national TV channels after we recovered over a billion dollars in settlements for the victims of defective drugs. Our attorneys do really care about knowing a victims’ history. Every time a client asks for our help, we know that there’s a tale of pain and suffering behind it, and understand how heavy the burden of losing someone you love can be. Winning in court may be the only way to cope with the financial draining caused by medical expenses, but most importantly, may finally bring the pharmaceutical companies who harmed you to justice. Our Law Group has all the experience required to stand up against even the largest corporations, and our skilled personal injury attorneys have passionately fought their legal battles to defend the rights of injured people for decades. We will answer your call immediately, and we will provide you a legal consultation to evaluate your legal options for free. Call us to receive the highest Xarelto injury settlement amount possible.
Life-Threatening Side Effects
Did you take Xarelto and develop a stroke, uncontrolled bleeding or any other serious complication? Fill out our Free lawsuit Review form to find out your possible legal options.
Free Xarelto Case Review
Why our law firm keeps filing lawsuits against Xarelto
One of the most bothering inconveniences of taking old-generation blood thinners such as Warfarin was the necessity of adopting a weekly blood test routine. Together with the annoying dietary restrictions, and the constant dosage adjustment required, Warfarin therapy proved to be burdensome and downright annoying for many people. That was the same reason rivaroxaban became an incredibly successful product in such a short time. Xarelto’s biggest selling points were its unique one-size-fits-all dosage, as well as the freedom it left patients from enduring any monitoring routines and dietary restrictions. Since 2013, many popular commercials hyped this medication’s superiority over its competitors. However, many plaintiffs alleged that the drugmaker simply overstated its safety and effectiveness caring only to increase the profits. The same characteristics that make rivaroxaban more appealing to patients make it also more dangerous to their health. However, many people just don’t know how dangerous the medication could be. Those who eventually knew the truth about it, in fact, were the unlucky ones who suffered the tremendous effects of the dreaded uncontrollable bleeding. The scary truth about the side effects, in fact, hit like a truck to many patients’ lives, forcing them to ask for help from our lawyers to file a litigation. Over 7,000 lawsuits have been filed against this medication in the last few months – a number that provides invaluable evidence on how many people keep being injured.
This blood thinner has a very low therapeutic index, meaning that its safe dosage is dangerously close to the one where the drug starts becoming toxic. Even a small shift in those biological activities that every day flush medications out of our systems may lead to a potentially harmful (or even lethal) overdose. For this same reason, Warfarin required constant monitoring in the first place, as blood testings were the primary instrument through which doctors kept their patients’ health checked. “Knowledge is power,” said Sir Francis Bacon, and by knowing whenever the drug dose reached a dangerous blood level in their bodies, people prevented Warfarin from harming and injuring them. The lack of monitoring associated with Bayer’s anticoagulant instead, although it may seem more convenient, it’s also much more dangerous. On the other hand, the infamous Xarelto “one-dosage-fits-all” model is another reason this medication can threaten the very life of many people. From a physiological point of view, a 110 pounds human being is very different from another one who weighs 200 lbs, so there’s no way that same dose could be ideal for them both. Similarly, a young woman’s kidneys can flush this drug at a much higher rate than an elderly one, so prescribing to both of them the same dosage could actually cause a lethal overdose on the latter one. Some of the most dangerous adverse reactions such as a stroke or a gastrointestinal bleeding may, in fact, outright kill a patient due to the absence of a proper antidote to reverse this drug’s action.
Surgical wounds after hip or knee replacements
Bleeding events are probably the most publicized complications of this drug as they can cause a patient’s death. However, rivaroxaban is also linked to several other severe adverse reactions, including a higher occurrence of infections in surgical wounds after hip or knee replacements interventions. The risk for infection and wound leakage is four-fold higher when a patient is taking this drug. This kind of complications often forces patients to get back to the operating room to receive additional surgery. This anticoagulant is used to prevent blood clots from forming in the lower limbs after a joint replacements surgery. However, there are many other equally effective options available for patients. Doctors can still prevent blood clots with other medications such as heparins or aspirin, or mechanically with compression stockings and physical rehabilitation.
Xarelto Stroke – A compelling reason to file a lawsuit
Among the various types of bleedings associated with rivaroxaban, brain bleeding (which is a type of stroke) is one of the most dangerous. Medical literature only described a single intracranial haemorrhage case study of a patient who used Xarelto, but brain bleeding is still one of the principal risks listed in this medication label. Just like all other uncontrolled bleeding events, cerebral bleeding can be an alarming side effect of the drug due to the absence of a proper antidote to reverse its action. All anticoagulants may, in fact, cause brain strokes, but differently to what happens with Vitamin K inhibitors such as Warfarin, if a patient is taking rivaroxaban, once the haemorrhage starts doctors have no way to stop it. A cerebral bleeding may require hours to subside, and while physicians wait for the medication to be flushed out from the subject’s body, the damage caused could be either permanent or even fatal.
Gastrointestinal Bleeding Lawsuit
Several plaintiffs who filed a lawsuit against the pharmaceutical companies who manufacture rivaroxaban complained about gastrointestinal haemorrhages (GI bleedings). This condition is one of the most common forms of hidden bleeding caused by this dangerous blood thinner. GI bleeding has been found to be frequent in the elderly patients and those who are currently under treatment with other medications such as nonsteroidal anti-inflammatory drugs (NSAIDs). It includes haemorrhages of the stomach, small intestine, colon, rectum, esophagus and anus (hemorrhoids). Several gastrointestinal bleeding lawsuits have been filed over the course of the last two years, so if your stomach hurts when you’re taking Xarelto, maybe that’s a warning symptom you should not overlook.
Xarelto Multidistrict Litigation (MDL)
The number of federal lawsuits keeps growing, reaching almost 7,000 total cases as of October 2016. Due to the high number of litigations that have been filed, the U.S. Judicial Panel on Multidistrict Litigation consolidated these cases into a multidistrict litigation (MDL Number 2592) in the United States District Court for the Eastern District of Louisiana presided over by Judge Eldon Fallon, and a mass tort class action in Philadelphia, Pennsylvania. An MDL is used to speed up the legal procedures by consolidating many cases into a single one, choosing some of them as the most representative ones (in this case, four cases have been selected). If your dispute becomes a part of an MDL, you will still keep your own lawyer, and your case will be handled as an individual one.
McGowan v. Janssen
In 2014, Ruth McGowan, the daughter of Thomas Dunkley, filed a lawsuit on behalf of her deceased father. The dispute claims that Dunkley was prescribed the medication Xarelto to prevent his risk of stroke. However, after only a month of taking the drug, he died after suffering from a severe bleeding in his brain that doctors were unable to stop. The plaintiff accuses Janssen and Bayer of concealing the severity of the risks associated with rivaroxaban and of not properly testing the drug before it was distributed on the market.
Packard v. Janssen
The wife of William Packard filed a lawsuit against Bayer and Janssen on behalf of her deceased husband. According to the litigation, the plaintiff claims William was prescribed Xarelto for atrial fibrillation and continued to take the drug for six months until he suffered fatal bleeding in his brain. Doctors attempted to alleviate the cerebral pressure by drilling a hole into his skull. Unfortunately, they were unable to stop the haemorrhage and he was pronounced dead. Packard claims the drug manufacturers failed to warn the public that there was no antidote available to manage emergencies such as this.
Current Status of the Xarelto Products Liability Litigation
Due to the statute of limitations, all claims not brought in time will be barred so it’s imperative to file your dispute as soon as possible before time runs out. Recently, the parties have requested an amendment to Case Management Order (CMO) No. 2 to reschedule the upcoming trial dates due to logistical issues that may be caused by the NBA All-Star game. On September 21, 2016, Judge Eldon Fallon scheduled the initial bellwether trial dates for next March, while the other cases in the Philadelphia mass tort have been postponed to August 2017. Also, since the quantity of complaints literally flooded the court, Pretrial Order 10A extended the deadline to file a lawsuit in the MDL by another 90 days up until February. Product liability lawyers got more time to reviewing whether their clients are entitled to receive financial compensation before they are summoned to court.
Why you need our group of competent Xarelto attorneys
Medical bills and hospitalization expenses may become a burden so heavy they may ruin a family’s finances. Financial draining is often coupled with emotional stress, especially when one needs to leave his job to properly take care of a relative who’s been harmed by a medicine’s complications. Filing a dispute in court could be a family’s last resort to pay their medical bills, and to receive a proper compensation for all their suffering and pain. It could also prevent other people from facing the same fate, as the FDA may issue a recall or, at least, force the pharmaceutical companies to change their marketing policies.
Today there is no known standard settlement amount for this type of litigation. Your final compensation may vary depending on the damage you suffered, and the types of injuries you had to sustain. If you or a member of your family suffered an injury after using this medication, you might have legal options to ask for a reward in court. Our Law Group will provide you with the best-qualified attorney to provide assistance with your particular case. The right lawyer may help you get the money you require to pay medical bills and other expenses. Our Xarelto injury attorneys are thoroughly trained and specialized in dealing with the dreaded Big Pharma. They know exactly what to do to grant you proper compensation for all your sufferings. As first trial dates in the class action suit against the drug manufacturing company of Xarelto are set, the window narrows to submit a claim for an injury settlement. We can provide you a free initial consultation to evaluate your legal options. Contact us by completing the form that appears on this page or Call us at 1-800-553-0710. You can Read our FAQs to know more about rivaroxaban, or ask for free legal advice now.
Article written by: Dr. Claudio Butticè, Pharm.D. and designed by Luke Kist
Last updated: October 19, 2016
- U.S. Food and Drug Administration (FDA). “MEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets” Reference ID: 3688029. (Accessed August 2016).
- U.S. Food and Drug Administration (FDA). “Adverse Event Reporting System (AERS). (2011)” (Accessed March 2016)
- Hanley JP, “Warfarin reversal” J Clin Pathol. 2004 Nov; 57(11): 1132–1139.
- Institute for Safe Medication Practices (ISMP) “ISMP List of High-Alert Medications in Acute Care Settings” (Accessed August 2016)
- Davidson, B. L., et al. “Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin.” JAMA Intern Med. 2014;174(6):947-953. doi:10.1001/jamainternmed.2014.946.
- “Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.” Prescrire Int. 2013 Jun;22(139):155-9.
- Patel MR, et al; “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.” N Engl J Med. 2011;365(10):883-891.
- Budnitz DS, et al. “Emergency Hospitalizations for Adverse Drug Events in Older Americans” N Engl J Med 2011; 365:2002-2012 November 24, 2011
- Baglin TP, Keeling DM, Watson HG; British Committee for Standards in Haematology “Guidelines on oral anticoagulation (warfarin): third edition–2005 update”. Br J Haematol. 2006 Feb;132(3):277-85.
- Institute for Safe Medication Practices (ISMP) “QuarterWatch Monitoring FDA MedWatch Reports – Why Reports of Serious Adverse Drug Events Continue to Grow – October 3, 2012 – Data from 2012 Quarter 1” (Accessed July 2016)
- Raunsø J, et al. “Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation”. Eur Heart J. 2012 Aug;33(15):1886-92.
- Institute for Safe Medication Practices (ISMP) “QuarterWatch Monitoring FDA MedWatch Reports – Anticoagulants the Leading Reported Drug Risk in 2011 – May 31, 2012 – New Data from 2011 Quarters 3 – 4” (Accessed June 2015)
- Hsien-Yen Chang, Meijia Zhou, Wenze Tang, G Caleb Alexander, Sonal Singh: “Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study” BMJ 2015;350:h1585
- Frank Siebelt, Jonathan Gould, William Hardy: “Bayer faces lawsuits in United States over Xarelto: paper” Reuters website, June 14, 2014. (Accessed January 2016)
- Paul Harper, Laura Young, Eileen Merriman: “Bleeding Risk with Dabigatran in the Frail Elderly” N Engl J Med 2012; 366:864-866